Literature DB >> 29917056

Sustained Activation of Postsynaptic 5-HT2A Receptors Gates Plasticity at Prefrontal Cortex Synapses.

Coralie Berthoux1, Alexander Barre1, Joël Bockaert1, Philippe Marin1, Carine Bécamel1.   

Abstract

The prefrontal cortex (PFC) plays a key role in many high-level cognitive processes. It is densely innervated by serotonergic neurons originating from the dorsal and median raphe nuclei, which profoundly influence PFC activity. Among the 5-HT receptors abundantly expressed in PFC, 5-HT2A receptors located in dendrites of layer V pyramidal neurons control neuronal excitability and mediate the psychotropic effects of psychedelic hallucinogens, but their impact on glutamatergic transmission and synaptic plasticity remains poorly characterized. Here, we show that a 20-min exposure of mouse PFC slices to serotonin or the 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) produces a long-lasting depression of evoked AMPA excitatory postsynaptic currents in layer V pyramidal neurons. DOI-elicited long-term depression (LTD) of synaptic transmission is absent in slices from 5-HT2A receptor-deficient mice, is rescued by viral expression of 5-HT2A receptor in pyramidal neurons and occludes electrically induced long-term depression. Furthermore, 5-HT2A receptor activation promotes phosphorylation of GluA2 AMPA receptor subunit at Ser880 and AMPA receptor internalization, indicating common mechanisms with electrically induced LTD. These findings provide one of the first examples of LTD gating under the control of a G protein-coupled receptor that might lead to imbalanced synaptic plasticity and memory impairment following a nonphysiological elevation of extracellular serotonin.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  5-HT2A receptor; layer I/V synapses; long-term depression; prefrontal cortex; serotonin

Mesh:

Substances:

Year:  2019        PMID: 29917056     DOI: 10.1093/cercor/bhy064

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  10 in total

Review 1.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Cortical Tuning is Impaired After Perceptual Experience in Primary Visual Cortex of Serotonin Transporter-Deficient Mice.

Authors:  Alexandr Pak; Alexander A Chubykin
Journal:  Cereb Cortex Commun       Date:  2020-09-16

3.  The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex.

Authors:  Lynette A Desouza; Madhurima Benekareddy; Sashaina E Fanibunda; Farhan Mohammad; Balaganesh Janakiraman; Utkarsha Ghai; Tamar Gur; Julie A Blendy; Vidita A Vaidya
Journal:  Front Mol Neurosci       Date:  2021-12-24       Impact factor: 5.639

4.  Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.

Authors:  Christopher W Thomas; Cristina Blanco-Duque; Benjamin J Bréant; Guy M Goodwin; Trevor Sharp; David M Bannerman; Vladyslav V Vyazovskiy
Journal:  Transl Psychiatry       Date:  2022-02-23       Impact factor: 6.222

Review 5.  Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

Authors:  Athanasios Markopoulos; Antonio Inserra; Danilo De Gregorio; Gabriella Gobbi
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

6.  Clozapine prevented social interaction deficits and reduced c-Fos immunoreactivity expression in several brain areas of rats exposed to acute restraint stress.

Authors:  Rodolpho Pereira de Oliveira; José Simões de Andrade; Marianna Spina; João Vítor Chamon; Paulo Henrique Dias Silva; Ana Keyla Werder; Daniela Ortolani; Lucas de Santana Cardoso Thomaz; Simone Romariz; Daniel Araki Ribeiro; Beatriz Monteiro Longo; Regina Célia Spadari; Milena de Barros Viana; Liana Melo-Thomas; Isabel Cristina Céspedes; Regina Cláudia Barbosa da Silva
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

7.  Classic Psychedelic Drugs: Update on Biological Mechanisms.

Authors:  Franz X Vollenweider; John W Smallridge
Journal:  Pharmacopsychiatry       Date:  2022-01-25       Impact factor: 2.544

8.  Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.

Authors:  Dóra Révész; Genís Ona; Giordano N Rossi; Juliana M Rocha; Rafael G Dos Santos; Jaime E C Hallak; Miguel Á Alcázar-Córcoles; José C Bouso
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 5.435

9.  Early 5-HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse.

Authors:  Al Mahdy Hamieh; Angelina Rogliardo; Philippe Marin; Carine Bécamel; Coralie Berthoux; Emilie L Doucet; Camille Coudert; Fabrice Ango; Katarzyna Grychowska; Séverine Chaumont-Dubel; Pawel Zajdel; Rafael Maldonado; Joël Bockaert
Journal:  EMBO Mol Med       Date:  2020-04-24       Impact factor: 14.260

Review 10.  Catalysts for change: the cellular neurobiology of psychedelics.

Authors:  Matthew I Banks; Zarmeen Zahid; Nathan T Jones; Ziyad W Sultan; Cody J Wenthur
Journal:  Mol Biol Cell       Date:  2021-06-01       Impact factor: 4.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.